Argimiro Suarez
Academia Nacional de Medicina
6 Papers
65 Citations
Argimiro Suarez is an academic researcher from Academia Nacional de Medicina. The author has contributed to research in topics: Vincristine & Maintenance therapy. The author has an hindex of 6, co-authored 6 publications.
Chat about Author
Papers
Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Marcos C. Morgenfeld,Alfredo Pavlovsky,Argimiro Suarez,Nilda Somoza,Santiago Pavlovsky,Marcio Palau,Carlos A. Barros +6 more
TL;DR: One hundred ninety patients who had advanced active Hodgkin's disease, lymphosarcoma, or reticulum cell sarcoma were treated with a combination of cyclophosphamide, vincristine, procarbazine, and prednisone given in a cyclical fashion every month.
Induction and maintenance of remission in acute leukemia
Santiago Pavlovsky,Jorge A. Peñalver,Mariana Eppinger-Helft,Federico Sackmann Muriel,Luis J. Bergna,Argimiro Suarez,Guillermo Vilaseca,Alberto Andino Pavlovsky,Alfredo Pavlovsky +8 more
TL;DR: There was no statistically significant difference between the two maintenance regimens of vincristine, daunorubicin, and prednisone for induction followed by consolidation courses every 6 months with these drugs and either 6‐mercaptopurine and methotrexate (plan A) or metotrexate alone (plan B) for maintenance of remission.
32
The relation between Epstein-Barr virus antibodies and clinical symptomatology and immunodeficiency in patients with Hodgkin's disease.
TL;DR: Patients in clinical relapse had higher anti‐EBV antibody titers than patients in remission or those in the control group, and Immunodeficient patients had significantly higherAnti‐VCA titers are related to immunodeficiencies.
20
Sequential therapy for induction and maintenance of remission in acute myeloblastic leukemia
Mariana Eppinger-Helft,Santiago Pavlovsky,Argimiro Suarez,Federico Sackmann Muriel,Guillermo Hidalgo,Alfredo Pavlovsky,Guillermo Vilaseca +6 more
TL;DR: A total of 114 previously untreated patients with myeloblastic leukemia was included in a sequential therapy protocol, and 48 obtained complete remission, 14 had partial remission, 16 failed to respond, and 36 died during the course of treatment.
18
Chemoimmunotherapy with Corynebacterium parvum in acute myelocytic leukemia.
Mariana Eppinger-Helft,Santiago Pavlovsky,Guillermo Hidalgo,Federico Sackmann Muriel,Argimiro Suarez,Guy Garay,Carlos Russo,Maria José Santos,Alfredo Macchi,Jose Mario Lein +9 more
TL;DR: This method seems useful in preventing central nervous system relapse in patients with acute myeloblastic leukemia, but does not seem to prolong complete remission.
14